Jennifer58
2022-01-18
Omg
BioNTech shares tumbled nearly 8% in morning trading<blockquote>BioNTech 股价早盘暴跌近 8%</blockquote>
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
1
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":697582026,"tweetId":"697582026","gmtCreate":1642518093369,"gmtModify":1642518093743,"author":{"id":3577529300728738,"idStr":"3577529300728738","authorId":3577529300728738,"authorIdStr":"3577529300728738","name":"Jennifer58","avatar":"https://static.tigerbbs.com/9a014efda004b6cc112e5d7968adf52f","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":32,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>Omg</p></body></html>","htmlText":"<html><head></head><body><p>Omg</p></body></html>","text":"Omg","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/697582026","repostId":1159142841,"repostType":4,"repost":{"id":"1159142841","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642516584,"share":"https://www.laohu8.com/m/news/1159142841?lang=zh_CN&edition=full","pubTime":"2022-01-18 22:36","market":"us","language":"en","title":"BioNTech shares tumbled nearly 8% in morning trading<blockquote>BioNTech 股价早盘暴跌近 8%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1159142841","media":"Tiger Newspress","summary":"BioNTech shares tumbled nearly 8% in morning trading. Israel sticks with 4th vaccine shot, sees Omic","content":"<p><html><head></head><body>BioNTech shares tumbled nearly 8% in morning trading. Israel sticks with 4th vaccine shot, sees Omicron waning in a week.<img src=\"https://static.tigerbbs.com/820a316803b5a9c6361c44c1007ab003\" tg-width=\"865\" tg-height=\"641\" width=\"100%\" height=\"auto\"/>Israel will continue to offer a fourth COVID-19 vaccine shot despite preliminary findings that it is not enough to prevent Omicron infections, a senior health official said on Tuesday, predicting contagions stoked by the variant will wane in a week.</p><p><blockquote><html><head></head><body>BioNTech 股价在早盘交易中暴跌近 8%。以色列坚持第四剂疫苗注射,看到奥密克戎在一周内减弱。一名高级卫生官员周二表示,尽管初步发现以色列不足以预防奥密克戎感染,但以色列将继续提供第四针新冠肺炎疫苗,并预测由该变种引发的感染将在一周内减弱。</body></html></blockquote></p><p>The fastest country to roll out vaccinations a year ago, Israel last month started offering a fourth shot - also known as a second booster - to its most vulnerable and high-risk groups.</p><p><blockquote>以色列是一年前最快推出疫苗接种的国家,上个月开始向其最脆弱和高危群体提供第四剂疫苗,也称为第二剂加强针。</blockquote></p><p>A preliminary study published by an Israeli hospital on Monday found that the fourth shot increases antibodies to even higher levels than the third but "probably" not enough to fend off the highly transmissible Omicron.</p><p><blockquote>以色列一家医院周一发表的一项初步研究发现,第四针将抗体提高到比第三针更高的水平,但“可能”不足以抵御高度传播的奥密克戎病毒。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech shares tumbled nearly 8% in morning trading<blockquote>BioNTech 股价早盘暴跌近 8%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech shares tumbled nearly 8% in morning trading<blockquote>BioNTech 股价早盘暴跌近 8%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2022-01-18 22:36</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>BioNTech shares tumbled nearly 8% in morning trading. Israel sticks with 4th vaccine shot, sees Omicron waning in a week.<img src=\"https://static.tigerbbs.com/820a316803b5a9c6361c44c1007ab003\" tg-width=\"865\" tg-height=\"641\" width=\"100%\" height=\"auto\"/>Israel will continue to offer a fourth COVID-19 vaccine shot despite preliminary findings that it is not enough to prevent Omicron infections, a senior health official said on Tuesday, predicting contagions stoked by the variant will wane in a week.</p><p><blockquote><html><head></head><body>BioNTech 股价在早盘交易中暴跌近 8%。以色列坚持第四剂疫苗注射,看到奥密克戎在一周内减弱。一名高级卫生官员周二表示,尽管初步发现以色列不足以预防奥密克戎感染,但以色列将继续提供第四针新冠肺炎疫苗,并预测由该变种引发的感染将在一周内减弱。</body></html></blockquote></p><p>The fastest country to roll out vaccinations a year ago, Israel last month started offering a fourth shot - also known as a second booster - to its most vulnerable and high-risk groups.</p><p><blockquote>以色列是一年前最快推出疫苗接种的国家,上个月开始向其最脆弱和高危群体提供第四剂疫苗,也称为第二剂加强针。</blockquote></p><p>A preliminary study published by an Israeli hospital on Monday found that the fourth shot increases antibodies to even higher levels than the third but "probably" not enough to fend off the highly transmissible Omicron.</p><p><blockquote>以色列一家医院周一发表的一项初步研究发现,第四针将抗体提高到比第三针更高的水平,但“可能”不足以抵御高度传播的奥密克戎病毒。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159142841","content_text":"BioNTech shares tumbled nearly 8% in morning trading. Israel sticks with 4th vaccine shot, sees Omicron waning in a week.Israel will continue to offer a fourth COVID-19 vaccine shot despite preliminary findings that it is not enough to prevent Omicron infections, a senior health official said on Tuesday, predicting contagions stoked by the variant will wane in a week.The fastest country to roll out vaccinations a year ago, Israel last month started offering a fourth shot - also known as a second booster - to its most vulnerable and high-risk groups.A preliminary study published by an Israeli hospital on Monday found that the fourth shot increases antibodies to even higher levels than the third but \"probably\" not enough to fend off the highly transmissible Omicron.","news_type":1,"symbols_score_info":{"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":3259,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/697582026"}
精彩评论